<DOC>
	<DOCNO>NCT01624246</DOCNO>
	<brief_summary>To evaluate pharmacokinetic ( PK ) profile ceftaroline avibactam adult augment renal clearance ( ARC ) .</brief_summary>
	<brief_title>Pharmacokinetic Study Ceftaroline Fosamil/Avibactam Adults With Augmented Renal Clearance</brief_title>
	<detailed_description>To evaluate single-dose pharmacokinetic ( PK ) profile ceftaroline avibactam follow intravenous ( IV ) administration ceftaroline fosamil/avibactam ( `` CXL '' ) adult augment renal clearance ( ARC ) .</detailed_description>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Avibactam</mesh_term>
	<criteria>Male female adult ≥ 18 ≤ 55 year old Augmented renal clearance , define : Estimated CrCl ≥ 115 mL/min ( calculate use modify CockcroftGault , measure 8hour urine collection ) Measured CrCl ≥ 140 mL/min ( 8hour urine collection ) Hospitalized diagnosed SIRS , define least 2 follow : Temperature ( oral , rectal , tympanic , core ) &gt; 38.5°C &lt; 35.0°C Heart rate &gt; 90 beats/min Respiratory rate &gt; 20 breaths/min PaCO2 &lt; 32 mmHg Leukocytosis ( &gt; 12,000 white blood cell [ WBC ] /mm3 ) , leukopenia ( &lt; 4000 WBC/mm3 ) , bandemia ( &gt; 10 % immature neutrophils [ band ] regardless total peripheral WBC ) Requires indwell urinary bladder catheter per standard care ( end 8hour urine collection ) History know hypersensitivity allergic reaction cephalosporin βlactam antimicrobial ( eg , penicillin ) History chronic kidney disease , hemodialysis , peritoneal dialysis ; history acute renal replacement therapy ( eg , hemodialysis , hemofiltration ) associate current illness Suspected rhabdomyolysis creatine kinase &gt; 10,000 U/L Significant anemia define hemoglobin &lt; 9 g/dL hematocrit &lt; 27 % Transfusion pack red blood cell ( PRBC ) whole blood within 24 hour study drug infusion anticipate need transfusion last PK blood sample collect If female , currently pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>